37 employees
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
2019
$31M
from 6 investors over 6 rounds
Vico Therapeutics B.V. raised $31M on July 29, 2020
Investors: Kinled Holding Ltd, Pureos Bioventures, Pontifax Venture Capital, Idinvest Partners, EQT Life Sciences and Polaris Partners